New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
STW

State Street SPDR MSCI Europe Health Care UCITS ETF

The STW Exchange Traded Fund (ETF) is provided by State Street Investment Management. It is built to track an index: MSCI Europe Health Care Capped 35/20 Index. The STW ETF provides physical exposure, so by buying it you actually own parts of all the 38 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

€232.25
+€2.9 (+1.24%) 2 days ago
7:00 AM 08/07/26 Closed
1D price range
€232.15€233.65
52W price range
€193.10€244.47
YTD Perf.
+3.07%
YTD Flows
Annualized volatility
Fund AuM
€573M
Share class AuM
€573M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE00BKWQ0H23
TER
0.18%
Inception date
12/5/2014
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Aug 7, 2026
-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
96.19%
Consumer Cyclicals
3.04%
Other
0.77%
Latest STW news

FAQ about STW

STW is a Passive ETF. This ETF provides exposure to Large and Mid-Cap European Health Care Equities.
STW tracks the MSCI Europe Health Care Capped 35/20 NTR Index - EUR, through a full replication replication method.
STW carries a total expense ratio (TER) of 0.18%, indicating the annual cost for holding the fund.
STW was introduced to the market on December 5, 2014. It trades on Norway, among other exchanges
State Street SPDR MSCI Europe Health Care UCITS ETF, STW, is provided by State Street Investment Management. Learn more about State Street Investment Management here.
STW oversees €573M in assets as of August 7, 2026.
STW follows a capitalizing, meaning it reinvests income within the fund.
As of June 30, 2026, STW has significant geographic allocations in Switzerland, United Kingdom and Denmark.
As of June 30, 2026, STW focuses largely on Healthcare and Consumer Cyclicals.
As of June 30, 2026, STW holds 38 positions in its portfolio, with 87.31% of assets concentrated in its top 15 holdings.
As of June 30, 2026, STW top three holdings include Roche Holding AG, Novartis AG and AstraZeneca PLC.
The base currency of STW is EUR.
Data as of 06/30/26
Roche Holding AG
15.59%
Novartis AG
15.46%
AstraZeneca PLC
15.22%
Novo Nordisk A/S
8.34%
GSK Plc
5.74%
Sanofi
5.04%
argenx SE
3.09%
EssilorLuxottica SA
3.04%
Bayer AG
2.93%
Lonza Group AG
2.56%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight